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EDITORIAL 
• QUALITY OF LIFE IN PSYCHIATRIC PATIENTS 
Ancient Indian Literature considers health 
as a broad and global concept represented by 
from independent dimensions of physical, 
psychological, social and spiritual well being 
(Charak Samhita,1949). This conceptualisation 
of health is even broader than the modern 
concept of health as accepted by WHO which 
aims at restoring "a state of complete physical, 
mental and social well being". Till the turn of 
last century the main focus of treatment was on 
saving the lives but with the development of 
medicine as a science there has been a 
conceptual shift from simply treating the. 
symptoms and prolonging life to improving the 
QOL of the patients. Chronic illnesses have 
replaced life threatening conditions as major 
challenges to clinicians and have brought with 
them issues such as: cost of treatment, disability, 
social impairment and burden of care. These 
issues directly or indirectly influenced the 
patients sense of well being and self esteem. A 
number of factors have contributed to sucn 
development - life threatening conditions have 
been replaced by chronic illnesses and with this 
the cost of treatment/care has become an 
important parameter. Cost utility, the concept 
which involves choice between different methods 
of treatment based on improvement it provides 
and the quality of life it gives, is increasingly in 
use in health care evaluations. In addition, family 
and patient's groups participation in decision 
about health care is also being seen as their 
desire to get therapies for better quality of life. 
The pharmaceutical industry has been quick to 
seize the opportunity and is motivated by 
genuine desire to develop better medications so 
that they can give better QOL to the patients. 
After all what matters for the individual patient 
with a chronic illness is how such an individual 
feels and functions on long term drug therapy. 
The concept of quality of life is not so new. 
However, in its current form it was launched by 
late American President, Lyndon B. Johnson, 
during his presidential campaign in 1964, when 
he gave the idea that people were entitled to "a 
good quality of life". Thereafter, quality of life 
has been recognised as one of the mankind's 
fundamental needs. Initially, only few knew 
exactly what it meant, but it was evident from its 
wider acceptance that this concept was an 
important one. In simple words quality of life is 
a person's own subjective view of well being and 
satisfaction with his/her life. It is therefore 
completely subjective feeling state (Joyce, 
1992). Rehumanising medicine and freeing it of 
high tech objective is the goal of the proponents 
of quality of life concept. 
The WHO officially recognizes QOL as a 
subjective notion by stating that "the individual 
himself/herself should be the arbiter of their 
quality of life". Dunbar & Stroker (1992) pointed 
out that the difference between "self now" and 
"ideal self could be used as a measure of QOL. 
Another important aspect of QOL is that 
it is different from an individuals' health status 
and is a much broader term. It includes health 
status as well as other features such as 
environment, income and living standard. More 
recently, the WHO has explained that the-division 
between these two concepts was that "QOL is 
defined by the patients subjective disadvantage 
of being ill, in contrast to health status, which is 
defined by clinical disability caused by disease". 
For example, although a patient who is 
prescribed lithium for a mood disorder may be 
in good health (stabilized), an increase in weight 
or having to take medicine daily may result in a 
low QOL. QOL therefore represents the impact 
of an illness and its therapy on the functional 
status of a patient, as perceived by the patient 
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himself or herself (Schipper et al.,1990). It is 
more than symptomatic improvement or 
deterioration and includes assessment of number 
of major domains specifically, illness related and 
treatment related impairments as well as 
psychosocial performance. 
Various studies were conducted in USA 
during 1980's (Lehman,1988; Lehman & Burns, 
1990; Spilker,1990; lntagliata.1982) using 
various quality of life measures. Results have 
shown that no single quality of life measures 
emerged as definitive changes within QOL 
domains independent of treatment may influence 
the participation and the effectiveness of 
treatment; measures of treatment benefits and 
adverse effects do not yield, conclusions 
regarding how a patient's QOL is affected as 
filtered through than person's own values beliefs 
and judgements. 
Future scales for assessment of QOL 
need to be more specific for psychiatric 
population. The scales need to pick-up small 
changes which are expected in psychiatric 
patients. Since QOL. is multidimensional 
construct it has to tape a number of domains 
including illness related and treatment related 
issues as well as psychosocial findings. 
The concept of QOL is quite new to 
psychiatry and has gained significance as a 
consequence of shift towards deinstitutionalisation 
and practice of community psychiatry. It is 
believed that the QOL of mentally ill would be 
greatly enhanced by living with family and in his 
own community rather than within the cold and 
impersonal walls of a mental hospital. There are 
a multitude of reasons which force us to stop 
thinking of psychiatric illnesses in terms of health 
status alone and adopt a wider vision 
encompassing QOL. Firstly, psychiatrists usually 
do not mention the side effects or social 
incapacities associated with the treatments they 
give to their patients. As many psychiatric 
illnesses require long term treatment, social and 
work factors play an important role bringing down 
the QOL. Secondly, diagnosis of an illness in 
psychiatry is not based on highly objective criteria 
as is the case with hypertension or arthritis. 
Because of this subjectivity sometimes it becomes 
very difficult to decide to whom, why or when 
to prescribe drugs. For example giving 
antidepressants to anyone who feels "unhappy" 
means that we are treating poor QOL with drugs, 
which is ridiculous. In such case ethics requires 
us to differentiate between illness and poor QOL 
and to answer the patient's problems adequately. 
Thirdly with the upsurge of chronic illnesses, the 
economic burden associated with these illnesses 
has become a-major concern (Atkinson et al., 
1997; Lehman, 1996). Economic burden and cost-
effectiveness of the treatment needs to be 
evaluated carefully especially in country like ours. 
The importance of health related quality 
of life assessments in psychiatric patients in our 
country needs to be recognised. These 
assessments involve restructuring of clinical 
thinking from symptom improvement to 
improvement in the functional status of the 
patient. Such assessments can improve clinical 
decision making and can assist in making benefit 
versus risk judgements on any therapeutic 
approach. Any form of treatment should consider 
the holistic quality of life alongwith the subjective 
quality of life as an important outcome measure. 
It will serve as a reminder to clinicians that drugs 
are only a component in the wholesome 
management of psychiatric illnesses (Priebe et 
al.,1996). Drug regulatory bodies may be 
promoted to make QOL assessments a 
requirement for approval of newer drugs 
alongwith therapeutic and side effect 
evaluations. As health costs are becoming a 
major concern, data from such assessments can 
be used for allocation of resources as well as 
comparison of therapies. For all this to be 
accomplished there is a need for focusing 
research interests on the development of valid 
and reliable measures of QOL suited to the 
needs of the local psychiatric populations. 
In our country quality of life assessment 
would also have to take into account social, 
economical and educational circumstances (Sell 
& Nagpal,1985). 
Thus, quality of life and subjective well 
being have been relevant constructs and subject 
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of empirical research for several decades all over 
the world but not that much in India. To what 
extent quality of life is a useful criterion for the 
planning and evaluation of mental health 




Atkinson,M., Zibin.S. & Chuang.H. 
(1997) Characterising quality of life among 
patients with chronic mental illness : a critical 
examination of the self report methodology. 
American Journal of Psychiatry, 154, 1, 99-105. 
Charak Samhita (1949) Warba Ayurvedic 
Society, (Ed.) Kumar, Gulab, Jam Nagar. 
Dunbar, G. & Stroker, M. (1992) The 
development of a questionnaire to measure 
quality of life in psychiatric patients. British 
Journal Econ., 4, 63-73. 
Intagliata, J.(1982) Improving the quality 
of community care of chronically, mentally 
disabled : the role of case management. 
Schizophrenia Bulletin, 8, 655-675. 
Joyce, C.R.B. (1992) Report from 
European Standard for Clinical Trials Meeting 
in Strassbourg, 23-24 May,1991, on issues of 
concern in the standardisation and harmonisation 
of drug trials in Europe. Health related quality of 
life session. Quality of Life News, 1, 3, 10. 
Lehman, A.F.(1988) A quality of life 
interview for chronically mentally ill. Eval. Prog. 
Plann., 11, 51-62. 
Lehman, A.F.(1996) Measures of quality 
of life among persons with severe and persistent 
mental disorders. Social Psychiatry & Psychiatric 
Epidemiology, 31, 2, 78-88. 
Lehman, A.F. & Burns,B.J.(1990) 
Severe mental illness in the community. In : 
Quality of Life Assessment in Clinical Trials, (Ed.) 
Spilker, B., New York : Raven Press. 
Priebe, S., Kaiser, W. & Huxley,P.(1996) 
Quality of life as a planning and evaluation 
criterion in psychiatric management. Gesundhei 
Tswesen, 58, 1 (suppl.), 86-90 
Schipper.H., Clinch, J. & Powell.V. 
(1990) Definitions and conceptual issues, In : 
Quality of Life Assessment in Clinical Trials, (Ed.) 
Spilker, B., New York : Raven Press. 
Sell.H. & Nagpal,R.(1985) Subjective 
well being. SERO regional health papers No.7, 
WHO, New Delhi. 
Spilker, B. (1990) Introduction, In: Quality 
of Life Assessment in Clinical Trials, (Ed.) S piker, 
B., New York : Raven Press. 
WHO (1974) The constitution of the World 
Health Organisation. WHO Chronicle, 1, 29. 
WHO (1991) Meeting on the assessment 
of QOL in health care. Geneva, 11-15 Feb., 1991. 
MNH/PSF/914. 
279 